by Older Lundy Attorneys At Law | Feb 9, 2026 | Business Litigation, Chase Howard, Healthcare Law
The FDA has made a public stance not taken since the early days of stem cell treatments, directly targeting the non-FDA approved GLP-1 drug market. This focus on enforcement targets compound pharmacies and clinics (brick and mortar as well as telehealth) that provide...
by Older Lundy Attorneys At Law | Feb 4, 2026 | Business Litigation, Chase Howard, Healthcare Law
What’s the Deal with Peptides? Lately, there seems to be a lot of confusion and interest regarding Peptides. While the current administration has a different view of food, drugs, and the like, guidance is confusing and the potential risk of enforcement should cause...
by Older Lundy Attorneys At Law | Jan 12, 2026 | Business Litigation, Chase Howard, Healthcare Law
COVID-Era Telemedicine Flexibilities for Controlled Substances – Again For the fourth time since the onset of the COVID-19 pandemic, the federal government has extended temporary rules allowing healthcare providers to prescribe certain controlled substances via...
by Older Lundy Attorneys At Law | Dec 10, 2025 | Business Litigation, Chase Howard, Healthcare Law
FDA Lifts Black Box Warning on Menopause HRT In a landmark shift, the FDA announced on November 10, 2025, the removal of its stringent “black box” warning from hormone replacement therapy (HRT) products for menopausal symptoms. This reverses a 20+ year...
by Older Lundy Attorneys At Law | Nov 25, 2025 | Business Litigation, Chase Howard, Geneva Hernandez, Healthcare Law, Intellectual Property Law, Taylor Woolfenden, Thomas Stanton
Tom Stanton, will lead Older Koch Lundy & Martino’s new Intellectual Property Group, along with attorneys Taylor Woolfenden and Geneva Hernandez and paralegal, Marina Ceschi. This team will handle all intellectual property matters, including trademarks,...
